{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:01:35Z","timestamp":1778043695035,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,11,17]],"date-time":"2008-11-17T00:00:00Z","timestamp":1226880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,11,17]],"date-time":"2008-11-17T00:00:00Z","timestamp":1226880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/bmt.2008.377","type":"journal-article","created":{"date-parts":[[2008,11,17]],"date-time":"2008-11-17T11:50:59Z","timestamp":1226922659000},"page":"717-723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study"],"prefix":"10.1038","volume":"43","author":[{"given":"M","family":"Schleuning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Judith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Jedlickova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"St\u00fcbig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Heshmat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Baurmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Schwerdtfeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,17]]},"reference":[{"key":"BFbmt2008377_CR1","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1200\/JCO.2005.07.061","volume":"23","author":"C Schmid","year":"2005","unstructured":"Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ . Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol 2005; 23: 5675\u20135687.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008377_CR2","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1182\/blood-2005-10-4165","volume":"108","author":"C Schmid","year":"2006","unstructured":"Schmid C, Schleuning M, Schwerdtfeger R, Hertenstein B, Mischak-Weissinger E, Bunjes D et al. Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. Blood 2006; 108: 1092\u20131099.","journal-title":"Blood"},{"key":"BFbmt2008377_CR3","doi-asserted-by":"publisher","first-page":"19445","DOI":"10.1074\/jbc.C500125200","volume":"280","author":"SM Ali","year":"2005","unstructured":"Ali SM, Sabatini DM . Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site. J Biol Chem 2005; 280: 19445\u201319448.","journal-title":"J Biol Chem"},{"key":"BFbmt2008377_CR4","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"DD Sarbassov","year":"2004","unstructured":"Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004; 14: 1296\u20131302.","journal-title":"Curr Biol"},{"key":"BFbmt2008377_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1182\/blood-2006-01-0329","volume":"108","author":"R Zeiser","year":"2006","unstructured":"Zeiser R, Nguyen VH, Beilhack A, Buess M, Schulz S, Baker J et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 2006; 108: 390\u2013399.","journal-title":"Blood"},{"key":"BFbmt2008377_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/00041552-200211000-00006","volume":"11","author":"RW Johnson","year":"2002","unstructured":"Johnson RW . Sirolimus (Rapamune) in renal transplantation. Curr Opin Nephrol Hypertens 2002; 11: 603\u2013607.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"BFbmt2008377_CR7","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1016\/S0041-1345(03)00234-3","volume":"35","author":"JF Trotter","year":"2003","unstructured":"Trotter JF . Sirolimus in liver transplantation. Transplant Proc 2003; 35: S193\u2013S200.","journal-title":"Transplant Proc"},{"key":"BFbmt2008377_CR8","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood-2006-09-046219","volume":"109","author":"C Cutler","year":"2007","unstructured":"Cutler C, Li S, Ho VT, Koreth J, Alyea E, Soiffer RJ et al. Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation. Blood 2007; 109: 3108\u20133114.","journal-title":"Blood"},{"key":"BFbmt2008377_CR9","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1097\/00007890-200112270-00010","volume":"72","author":"AI Benito","year":"2001","unstructured":"Benito AI, Furlong T, Martin PJ, Anasetti C, Appelbaum FR, Doney K et al. Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease. Transplantation 2001; 72: 1924\u20131929.","journal-title":"Transplantation"},{"key":"BFbmt2008377_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbmt.2004.10.004","volume":"11","author":"LJ Johnston","year":"2005","unstructured":"Johnston LJ, Brown J, Shizuru JA, Stockerl-Goldstein KE, Stuart MJ, Blume KG et al. Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2005; 11: 47\u201355.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008377_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1365-2141.2005.05616.x","volume":"130","author":"DR Couriel","year":"2005","unstructured":"Couriel DR, Saliba R, Escalon MP, Hsu Y, Ghosh S, Ippoliti C et al. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol 2005; 130: 409\u2013417.","journal-title":"Br J Haematol"},{"key":"BFbmt2008377_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.bbmt.2007.02.003","volume":"13","author":"M Jurado","year":"2007","unstructured":"Jurado M, Vallejo C, P\u00e9rez-Sim\u00f3n JA, Brunet S, Ferra C, Balsalobre P et al. Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease. Biol Blood Marrow Transplant 2007; 13: 701\u2013706.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008377_CR13","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1038\/sj.onc.1204091","volume":"19","author":"M Hidalgo","year":"2000","unstructured":"Hidalgo M, Rowinsky EK . The rapamycin-sensitive transduction pathway as a target for cancer therapy. Oncogene 2000; 19: 6680\u20136686.","journal-title":"Oncogene"},{"key":"BFbmt2008377_CR14","doi-asserted-by":"publisher","first-page":"10314","DOI":"10.1073\/pnas.171076798","volume":"98","author":"MS Neshat","year":"2001","unstructured":"Neshat MS, Mellinghoff IK, Tran C, Stiles B, Thomas G, Petersen R et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR. Proc Natl Acad Sci USA 2001; 98: 10314\u201310319.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbmt2008377_CR15","doi-asserted-by":"publisher","first-page":"10320","DOI":"10.1073\/pnas.171060098","volume":"98","author":"K Podsypanina","year":"2001","unstructured":"Podsypanina K, Lee RT, Politis C, Hennessy I, Crane A, Puc J et al. An inhibitor of mTOR reduces neoplasia and normalizes p70\/S6 kinase activity in Pten\u2212\/\u2212 mice. Proc Natl Acad Sci USA 2001; 98: 10320\u201310325.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbmt2008377_CR16","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1200\/JCO.2004.08.116","volume":"22","author":"E Raymond","year":"2004","unstructured":"Raymond E, Alexandre J, Faivre S, Vera K, Materman E, Boni J et al. Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer. J Clin Oncol 2004; 22: 2336\u20132347.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008377_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1365-2141.2005.05360.x","volume":"128","author":"U Platzbecker","year":"2005","unstructured":"Platzbecker U, Haase M, Herbst R, H\u00e4nel A, Voigtmann K, Thiede CH et al. Activity of sirolimus in patients with myelodysplastic syndrome\u2014results of a pilot study. Br J Haematol 2005; 128: 625\u2013630.","journal-title":"Br J Haematol"},{"key":"BFbmt2008377_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/sj.leu.2404471","volume":"21","author":"T Haritunians","year":"2007","unstructured":"Haritunians T, Mori A, O\u2032Kelly J, Luong QT, Giles FJ, Koeffler HP . Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma. Leukemia 2007; 21: 333\u2013339.","journal-title":"Leukemia"},{"key":"BFbmt2008377_CR19","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1182\/blood-2002-11-3429","volume":"102","author":"Q Xu","year":"2003","unstructured":"Xu Q, Simpson S-E, Scialla TJ, Bagg A, Carroll M . Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 2003; 102: 972\u2013980.","journal-title":"Blood"},{"key":"BFbmt2008377_CR20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1101\/gad.887201","volume":"15","author":"AC Gingras","year":"2001","unstructured":"Gingras AC, Raught B, Sonenberg N . Regulation of translation initiation by RAP\/mTOR. Genes Dev 2001; 15: 807\u2013826.","journal-title":"Genes Dev"},{"key":"BFbmt2008377_CR21","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1182\/blood-2004-06-2494","volume":"105","author":"C Recher","year":"2005","unstructured":"Recher C, Beyne-Rauzy O, Demur C, Chicanne G, Dos Santos C, Mansat-De Mas V et al. Antileukemic activity of rapamycin in acute myeloid leukemia. Blood 2005; 105: 2527\u20132534.","journal-title":"Blood"},{"key":"BFbmt2008377_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1182\/blood-2006-08-039883","volume":"110","author":"SM Chan","year":"2007","unstructured":"Chan SM, Weng AP, Tibshirani R, Aster JC, Utz PJ . Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukaemia. Blood 2007; 110: 278\u2013286.","journal-title":"Blood"},{"key":"BFbmt2008377_CR23","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1097\/00007890-200005270-00019","volume":"69","author":"JC Hong","year":"2000","unstructured":"Hong JC, Kahan BD . Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management. Transplantation 2000; 69: 2085\u20132090.","journal-title":"Transplantation"},{"key":"BFbmt2008377_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7326\/0003-4819-144-7-200604040-00009","volume":"144","author":"L Champion","year":"2006","unstructured":"Champion L, Stern M, Isra\u00ebl-Biet D, Mamzer-Bruneel MF, Peraldi MN, Kreis H et al. Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients. Ann Intern Med 2006; 144: 505\u2013509.","journal-title":"Ann Intern Med"},{"key":"BFbmt2008377_CR25","first-page":"476","volume":"97","author":"E Mah\u00e9","year":"2005","unstructured":"Mah\u00e9 E, Morelon E, Lechaton S, Sang KH, Mansouri R, Ducasse MF et al. Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation 2005; 97: 476\u2013482.","journal-title":"Transplantation"},{"key":"BFbmt2008377_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/TP.0b013e3181613e65","volume":"85","author":"MP Smith","year":"2008","unstructured":"Smith MP, Newstead CG, Ahmad N, Lewington AJ, Tibble S, Lodge JP et al. Poor tolerance of sirolimus in a steroid avoidance regimen for renal transplantation. Transplantation 2008; 85: 636\u2013639.","journal-title":"Transplantation"},{"key":"BFbmt2008377_CR27","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1399-0012.2007.00686.x","volume":"21","author":"G Tenderich","year":"2007","unstructured":"Tenderich G, Fuchs U, Zittermann A, Muckelbauer R, Berthold HK, Koerfer R . Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients. Clin Transplant 2007; 21: 536\u2013543.","journal-title":"Clin Transplant"},{"key":"BFbmt2008377_CR28","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/j.1600-6143.2006.01282.x","volume":"6","author":"S Kuppahally","year":"2006","unstructured":"Kuppahally S, Al-Khaldi A, Weisshaar D, Valantine HA, Oyer P, Robbins RC et al. Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients. Am J Transplant 2006; 6: 986\u2013992.","journal-title":"Am J Transplant"},{"key":"BFbmt2008377_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","volume":"11","author":"C Cutler","year":"2005","unstructured":"Cutler C, Henry NL, Magee C, Li S, Kim HT, Alyea E et al. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 551\u2013557.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008377_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1182\/blood-2007-01-069294","volume":"110","author":"FM Marty","year":"2007","unstructured":"Marty FM, Bryar J, Browne SK, Schwarzberg T, Ho VT, Bassett IV et al. Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis. Blood 2007; 110: 490\u2013500.","journal-title":"Blood"},{"key":"BFbmt2008377_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fever A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BFbmt2008377_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204\u2013217.","journal-title":"Am J Med"},{"key":"BFbmt2008377_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BFbmt2008377_CR34","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912\u20132919.","journal-title":"Blood"},{"key":"BFbmt2008377_CR35","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1016\/j.transproceed.2007.09.040","volume":"39","author":"P De Simone","year":"2007","unstructured":"De Simone P, Petruccelli S, Precisi A, Carrai P, Doria R, Menichetti F et al. Switch to everolimus for sirolimus-induced pneumonitis in a liver transplant recipient\u2014not all proliferation signal inhibitors are the same: a case report. Transplant Proc 2007; 39: 3500\u20133501.","journal-title":"Transplant Proc"},{"key":"BFbmt2008377_CR36","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.bbmt.2008.02.009","volume":"14","author":"T Furlong","year":"2008","unstructured":"Furlong T, Kiem HP, Appelbaum FR, Carpenter PA, Deeg HJ, Doney K et al. Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors. Biol Blood Marrow Transplant 2008; 14: 531\u2013537.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008377_CR37","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.transproceed.2005.02.038","volume":"37","author":"F Nogueras","year":"2005","unstructured":"Nogueras F, Espinosa MD, Mansilla A, Torres JT, Cabrera MA, Mart\u00edn-Vivaldi R . Mycophenolate mofetil-induced neutropenia in liver transplantation. Transplant Proc 2005; 37: 1509\u20131511.","journal-title":"Transplant Proc"},{"key":"BFbmt2008377_CR38","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1097\/00007890-200004150-00009","volume":"69","author":"H Kreis","year":"2000","unstructured":"Kreis H, Cisterne JM, Land W, Wramner L, Squifflet JP, Abramowicz D et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 2000; 69: 1252\u20131260.","journal-title":"Transplantation"},{"key":"BFbmt2008377_CR39","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.bbmt.2005.04.006","volume":"11","author":"A Busca","year":"2005","unstructured":"Busca A, Locatelli F, Moscato D, Falda M . Sirolimus-related toxicity in stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 647\u2013649.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008377_CR40","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.bmt.1704957","volume":"35","author":"N Basara","year":"2005","unstructured":"Basara N, Baurmann H, Kolbe K, Yaman A, Labopin M, Burchardt A et al. Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group. Bone Marrow Transplant 2005; 35: 1011\u20131018.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008377_CR41","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/00007890-199502150-00014","volume":"59","author":"W Cao","year":"1995","unstructured":"Cao W, Mohacsi P, Shorthouse R, Pratt R, Morris RE . Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506. Transplantation 1995; 59: 390\u2013395.","journal-title":"Transplantation"},{"key":"BFbmt2008377_CR42","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1399-0012.2007.00669.x","volume":"21","author":"A Haririan","year":"2007","unstructured":"Haririan A, Morawski K, West MS, El-Amm JM, Doshi MD, Cincotta E et al. Sirolimus exposure during the early post-transplant period reduces the risk of CMV infection relative to tacrolimus in renal allograft recipients. Clin Transplant 2007; 21: 466\u2013471.","journal-title":"Clin Transplant"},{"key":"BFbmt2008377_CR43","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1097\/01.tp.0000290686.68910.bd","volume":"84","author":"JA Hill","year":"2007","unstructured":"Hill JA, Hummel M, Starling RC, Kobashigawa JA, Perrone SV, Ariz\u00f3n JM et al. A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus. Transplantation 2007; 84: 1436\u20131442.","journal-title":"Transplantation"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2008377.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008377","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008377.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T18:34:22Z","timestamp":1659119662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2008377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,17]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BFbmt2008377"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2008.377","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,17]]},"assertion":[{"value":"25 June 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}